2D and 3D radial multi-gradient-echo DCE MRI in murine tumor models with dynamic R*2-corrected R1 mapping

Magnetic Resonance in Medicine

Volumn 64, Issue 1, 2010, Pages 313-318

  Vautier, Julien ^a,b,c   Heilmann, Melanie ^a,b,d   Walczak, Christine ^a,b   Mispelter, Joël ^a,b   Volk, Andreas ^a,b  

^a INSTITUT CURIE   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

DCE MRI; Radial acquisition; Relaxometry; Respiratory motion; Tumor microvasculature; Tumor models

Indexed keywords

COMPUTERIZED TOMOGRAPHY; IMAGE RECORDING; MAGNETIC RESONANCE IMAGING; MAMMALS; MAPPING; PHANTOMS; RESPIRATORY MECHANICS;

DCE-MRI; RADIAL ACQUISITION; RELAXOMETRY; RESPIRATORY MOTIONS; TUMOR MICROVASCULATURE; TUMOR MODELS;

TUMORS;

GADOTERATE MEGLUMINE; CONTRAST MEDIUM;

ABDOMEN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; BREATHING; CANCER TISSUE; COLORECTAL TUMOR; CONTRAST ENHANCEMENT; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; MEASUREMENT; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHANTOM; PILOT STUDY; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; THREE DIMENSIONAL IMAGING; TUMOR MODEL; ANIMAL; COLORECTAL NEOPLASMS; DISEASE MODEL; IMAGE QUALITY; PROCEDURES; RADIOGRAPHY;

ANIMALS; COLORECTAL NEOPLASMS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; PHANTOMS, IMAGING;

EID: 77953939906     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22396     Document Type: Article

References (20)

1. Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, Jayson GC, Judson IR, Knopp MV, Maxwell RJ, McIntyre D, Padhani AR, Price P, Rathbone R, Rustin GJ, Tofts PS, Tozer GM, Vennart W, Waterton JC, Williams SR, Workman P. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer 2005;92:1599-1610.
2. 2 measurement for AIF assessment combined with DCE MRI in a mouse tumor model. Magn Reson Mater Phy 2007;20:193-203.
3. Heilmann M, Sourbron S, Walczak C, Biffar A, Vautier J, Peller M, Volk A. Combination of DCE and DSC MRI: Added value in the study of tumor vascularization. In: Proc Intl Soc Mag Reson Med 16, Toronto, Canada, 2008. p 446.
4. 1 measurements for improved perfusion and permeability studies in high field using dynamic contrast enhancement. Eur Radiol 2006;16:2083-2091.
5. Kuperman VY, Alley MT. Differentiation between the effects of T1 and T2* shortening in contrast-enhanced MRI of the breast. J Magn Reson Imaging 1999;9:172-176.
6. 2, and chemical-shift imaging. Magn Reson Med 1990;13:77-89.
7. Glover GH, Pauly JM. Projection reconstruction techniques for reduction of motion effects in MRI. Magn Reson Med 1992;28:275-289.
8. Bucholz E, Ghaghada K, Qi Y, Mukundan S, Johnson GA. Four-dimensional MR microscopy of themouse heart using radial acquisition and liposomal gadoliniumcontrast agent.Magn Reson Med 2008;60:111-118.
9. Song HK, Dougherty L, Schnall MD. Simultaneous acquisition of multiple resolution images for dynamic contrast enhanced imaging of the breast. Magn Reson Med 2001;46:503-509.
10. Beaumont M, Lamalle L, Segebarth C, Barbier EL. Improved k-space trajectory measurement with signal shifting. Magn Reson Med 2007; 58:200-205.
11. Jackson JI, Meyer CH, Nishimura DG, Macovski A. Selection of a convolution function for Fourier inversion using gridding. IEEE Trans Med Imaging 1991;10:473-478.
12. Rasche V, Proksa R, Sinkus R, Bornert P, Eggers H. Resampling of data between arbitrary grids using convolution interpolation. IEEE Trans Med Imaging 1999;18:385-392.
13. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging, 1: fundamental concepts. Magn Reson Med 1991;17:357-367.
14. Checkley D, Tessier JJ, Kendrew J, Waterton JC, Wedge SR. Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours. Br J Cancer 2003;89:1889-1895.
15. Wilmes LJ, Pallavicini MG, Fleming LM, Gibbs J, Wang D, Li KL, Partridge SC, Henry RG, Shalinsky DR, Hu-Lowe D, Park JW, McShane TM, Lu Y, Brasch RC, Hylton NM. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Imaging 2007;25:319-327.
16. Marzola P, Degrassi A, Calderan L, Farace P, Nicolato E, Crescimanno C, Sandri M, Giusti A, Pesenti E, Terron A, Sbarbati A, Osculati F. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma. Clin Cancer Res 2005;11: 5827-5832.
17. Dafni H, Kim SJ, Bankson JA, Sankaranarayanapillai M, Ronen SM. Macromolecular dynamic contrast-enhanced (DCE)-MRI detects reduced vascular permeability in a prostate cancer bone metastasis model following anti-platelet-derived growth factor receptor (PDGFR) therapy, indicating a drop in vascular endothelial growth factor receptor (VEGFR) activation. Magn Reson Med 2008;60: 822-833.
18. 2 estimates from a single k-space data set. Magn Reson Med 2005;54:549-559.
19. Weidensteiner C, Rausch M, McSheehy PM, Allegrini PR. Quantitative dynamic contrast-enhanced MRI in tumor-bearing rats and mice with inversion recovery TrueFISP and two contrast agents at 4.7 T. J Magn Reson Imaging 2006;24:646-656.
20. Graff BA, Vangberg L, Rofstad EK. Quantitative assessment of uptake and distribution of iron oxide particles (NC100150) in human melanoma xenografts by contrast-enhanced MRI. Magn Reson Med 2004; 51:727-735.